Abstract TP297: Hepatic Enzyme Elevation Among Patients Receiving Intensive Medical Treatment for High-Grade Intracranial Stenosis

Stroke 2026

View at publisher
Authors: Hatem Tolba, Ali A. Alsarah, Yilun Huang, Syed Gillani, Khalid Tolba, Adnan Iqbal Qureshi
DOI: 10.1161/str.57.suppl_1.tp297
Cited by: 0

Abstract

Background: High-dose statin therapy and aggressive blood pressure control in patients with transient ischemic attack (TIA) or non-disabling ischemic stroke from high-grade (70–99%) intracranial arterial stenosis may cause hepatic enzyme elevation, potentially impacting therapy adherence. Methods: Post-hoc analysis of SAMMPRIS trial participants receiving intensive medical therapy (LDL cholesterol target

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Cerebrovascular and Carotid Artery Diseases Acute Ischemic Stroke Management

Publication details

Journal / source
Stroke
Volume
57
Issue
Suppl_1
Publication date
29 January 2026
Language
EN